Increased expression of CD47 has been observed in multiple blood and solid tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), gastric cancer, ovarian cancer, colon cancer, hepatocellular cancer and other tumor cells. This evidence concerns the gene CD47 and acute myeloid leukemia.